Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease

Po Hsun Huang, Tse Min Lu, Tao Cheng Wu, Feng Yen Lin, Yung Hsiang Chen, Jaw Wen Chen, Shing Jong Lin

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

OBJECTIVE: We examined whether the combined use of high-sensitive C-reactive protein (hsCRP) and N-terminal-probrain natriuretic peptide (NT-proBNP) could increase the predictive value for future cardiovascular events. BACKGROUND: hsCRP and NT-proBNP both have been shown to be strong predictors of cardiovascular events in patients with coronary artery disease. Few data are, however, available to assess whether combined use of these two distinct biomarkers improves the risk stratification in predicting cardiovascular events. METHODS: A total of 205 participants with suspected coronary artery disease referred for coronary angiography were enrolled in the study. Plasma levels of hsCRP and NT-proBNP were measured before coronary angiography. Cox regression analyses were conducted for the 205 participants, with cardiovascular events being defined as nonfatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, and ischemic stroke. RESULTS: All patients were divided into four groups by using median values of hsCRP (1.1 mg/l) and NT-proBNP (472.6 fmol/ml): group 1, low hsCRP/low NT-proBNP (n=60); group 2, high hsCRP/low NT-proBNP (n=42); group 3, low hsCRP/high NT-proBNP (n=42); and group 4, high hsCRP/high NT-proBNP (n=61). During a median follow-up of 4 years, there were 84 cardiovascular events (41%): 11 events (18%) in group 1, 13 events (31%) in group 2, 20 events (48%) in group 3, and 40 events (66%) in group 4 (P

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalCoronary Artery Disease
Volume19
Issue number3
DOIs
Publication statusPublished - May 2008
Externally publishedYes

Fingerprint

Natriuretic Peptides
C-Reactive Protein
Coronary Artery Disease
Coronary Angiography
Percutaneous Coronary Intervention
Coronary Artery Bypass
Biomarkers
Stroke
Myocardial Infarction
Regression Analysis

Keywords

  • Coronary artery disease
  • High-sensitive C-reactive protein
  • N-terminal-probrain natriuretic peptide

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease. / Huang, Po Hsun; Lu, Tse Min; Wu, Tao Cheng; Lin, Feng Yen; Chen, Yung Hsiang; Chen, Jaw Wen; Lin, Shing Jong.

In: Coronary Artery Disease, Vol. 19, No. 3, 05.2008, p. 187-193.

Research output: Contribution to journalArticle

@article{9c31fd8604114e588ec98a8530612901,
title = "Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease",
abstract = "OBJECTIVE: We examined whether the combined use of high-sensitive C-reactive protein (hsCRP) and N-terminal-probrain natriuretic peptide (NT-proBNP) could increase the predictive value for future cardiovascular events. BACKGROUND: hsCRP and NT-proBNP both have been shown to be strong predictors of cardiovascular events in patients with coronary artery disease. Few data are, however, available to assess whether combined use of these two distinct biomarkers improves the risk stratification in predicting cardiovascular events. METHODS: A total of 205 participants with suspected coronary artery disease referred for coronary angiography were enrolled in the study. Plasma levels of hsCRP and NT-proBNP were measured before coronary angiography. Cox regression analyses were conducted for the 205 participants, with cardiovascular events being defined as nonfatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, and ischemic stroke. RESULTS: All patients were divided into four groups by using median values of hsCRP (1.1 mg/l) and NT-proBNP (472.6 fmol/ml): group 1, low hsCRP/low NT-proBNP (n=60); group 2, high hsCRP/low NT-proBNP (n=42); group 3, low hsCRP/high NT-proBNP (n=42); and group 4, high hsCRP/high NT-proBNP (n=61). During a median follow-up of 4 years, there were 84 cardiovascular events (41{\%}): 11 events (18{\%}) in group 1, 13 events (31{\%}) in group 2, 20 events (48{\%}) in group 3, and 40 events (66{\%}) in group 4 (P",
keywords = "Coronary artery disease, High-sensitive C-reactive protein, N-terminal-probrain natriuretic peptide",
author = "Huang, {Po Hsun} and Lu, {Tse Min} and Wu, {Tao Cheng} and Lin, {Feng Yen} and Chen, {Yung Hsiang} and Chen, {Jaw Wen} and Lin, {Shing Jong}",
year = "2008",
month = "5",
doi = "10.1097/MCA.0b013e3282f399e2",
language = "English",
volume = "19",
pages = "187--193",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease

AU - Huang, Po Hsun

AU - Lu, Tse Min

AU - Wu, Tao Cheng

AU - Lin, Feng Yen

AU - Chen, Yung Hsiang

AU - Chen, Jaw Wen

AU - Lin, Shing Jong

PY - 2008/5

Y1 - 2008/5

N2 - OBJECTIVE: We examined whether the combined use of high-sensitive C-reactive protein (hsCRP) and N-terminal-probrain natriuretic peptide (NT-proBNP) could increase the predictive value for future cardiovascular events. BACKGROUND: hsCRP and NT-proBNP both have been shown to be strong predictors of cardiovascular events in patients with coronary artery disease. Few data are, however, available to assess whether combined use of these two distinct biomarkers improves the risk stratification in predicting cardiovascular events. METHODS: A total of 205 participants with suspected coronary artery disease referred for coronary angiography were enrolled in the study. Plasma levels of hsCRP and NT-proBNP were measured before coronary angiography. Cox regression analyses were conducted for the 205 participants, with cardiovascular events being defined as nonfatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, and ischemic stroke. RESULTS: All patients were divided into four groups by using median values of hsCRP (1.1 mg/l) and NT-proBNP (472.6 fmol/ml): group 1, low hsCRP/low NT-proBNP (n=60); group 2, high hsCRP/low NT-proBNP (n=42); group 3, low hsCRP/high NT-proBNP (n=42); and group 4, high hsCRP/high NT-proBNP (n=61). During a median follow-up of 4 years, there were 84 cardiovascular events (41%): 11 events (18%) in group 1, 13 events (31%) in group 2, 20 events (48%) in group 3, and 40 events (66%) in group 4 (P

AB - OBJECTIVE: We examined whether the combined use of high-sensitive C-reactive protein (hsCRP) and N-terminal-probrain natriuretic peptide (NT-proBNP) could increase the predictive value for future cardiovascular events. BACKGROUND: hsCRP and NT-proBNP both have been shown to be strong predictors of cardiovascular events in patients with coronary artery disease. Few data are, however, available to assess whether combined use of these two distinct biomarkers improves the risk stratification in predicting cardiovascular events. METHODS: A total of 205 participants with suspected coronary artery disease referred for coronary angiography were enrolled in the study. Plasma levels of hsCRP and NT-proBNP were measured before coronary angiography. Cox regression analyses were conducted for the 205 participants, with cardiovascular events being defined as nonfatal myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, and ischemic stroke. RESULTS: All patients were divided into four groups by using median values of hsCRP (1.1 mg/l) and NT-proBNP (472.6 fmol/ml): group 1, low hsCRP/low NT-proBNP (n=60); group 2, high hsCRP/low NT-proBNP (n=42); group 3, low hsCRP/high NT-proBNP (n=42); and group 4, high hsCRP/high NT-proBNP (n=61). During a median follow-up of 4 years, there were 84 cardiovascular events (41%): 11 events (18%) in group 1, 13 events (31%) in group 2, 20 events (48%) in group 3, and 40 events (66%) in group 4 (P

KW - Coronary artery disease

KW - High-sensitive C-reactive protein

KW - N-terminal-probrain natriuretic peptide

UR - http://www.scopus.com/inward/record.url?scp=42349103685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42349103685&partnerID=8YFLogxK

U2 - 10.1097/MCA.0b013e3282f399e2

DO - 10.1097/MCA.0b013e3282f399e2

M3 - Article

C2 - 18418236

AN - SCOPUS:42349103685

VL - 19

SP - 187

EP - 193

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 3

ER -